Literature DB >> 22713126

COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.

Márcio Gerhardt Soeiro-de-Souza1, Rodrigo Machado-Vieira, Danielle Soares Bio, Carolina Martins Do Prado, Ricardo Alberto Moreno.   

Abstract

OBJECTIVE: The dopaminergic system plays an important role in the prefrontal cortex (PFC) and is believed to mediate cognitive dysfunction (CD) in bipolar disorder (BD). The enzyme catechol-O-methyltransferase (COMT) is involved in the catabolism of dopamine in the PFC, and an association between COMT single nucleotide polymorphisms (SNPs) and BD has been reported. COMT SNPs have also been associated with executive and working memory performance in healthy subjects, patients with schizophrenia, and euthymic BD patients. The objective of this study was to investigate the association between COMT SNPs and acute CD during BD mood episodes.
METHODS: Seventy-two symptomatic, medication-free subjects with bipolar I disorder (BD-I) and 76 healthy controls were evaluated using neuropsychological tests, and genotyped for COMT SNPs rs4680 and rs165599.
RESULTS: Patients undergoing mania and mixed episodes carrying the COMT allele G had better performance on executive function, memory, verbal fluency, and intelligence tests. Moreover, an interaction was detected between the COMT allele G and the Young Mania Rating Scale in BD CD.
CONCLUSIONS: Allele G from COMT SNPs rs4680 and rs165599 may represent reliable state-dependent predictors of global CD during manic and mixed episodes in BD. Further studies in larger samples are necessary to confirm these findings.
© 2012 John Wiley and Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22713126     DOI: 10.1111/j.1399-5618.2012.01030.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  7 in total

1.  The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.

Authors:  Morgane Milienne-Petiot; James P Kesby; Mary Graves; Jordy van Enkhuizen; Svetlana Semenova; Arpi Minassian; Athina Markou; Mark A Geyer; Jared W Young
Journal:  Neuropharmacology       Date:  2016-10-11       Impact factor: 5.250

2.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

3.  Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.

Authors:  Marco Bortolato; Consuelo Walss-Bass; Peter M Thompson; Jackob Moskovitz
Journal:  World J Biol Psychiatry       Date:  2016-07-26       Impact factor: 4.132

4.  The impact of cafeteria diet feeding on physiology and anxiety-related behaviour in male and female Sprague-Dawley rats of different ages.

Authors:  Wiebke Warneke; Susanne Klaus; Heidrun Fink; Simon C Langley-Evans; Jörg-Peter Voigt
Journal:  Pharmacol Biochem Behav       Date:  2013-11-21       Impact factor: 3.533

Review 5.  The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition.

Authors:  Sheree F Logue; Thomas J Gould
Journal:  Pharmacol Biochem Behav       Date:  2013-08-24       Impact factor: 3.533

Review 6.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

Review 7.  An examination of the language construct in NIMH's research domain criteria: Time for reconceptualization!

Authors:  Brita Elvevåg; Alex S Cohen; Maria K Wolters; Heather C Whalley; Viktoria-Eleni Gountouna; Ksenia A Kuznetsova; Andrew R Watson; Kristin K Nicodemus
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-03-10       Impact factor: 3.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.